C-Reactive
Protein
(CRP)
Marker used to assess inflammation and monitor response to treatment.
Procalcitonin
(PCT)
Biomarker specifically used to guide antibiotic therapy initiation and safe discontinuation.
Essential Single Biomarkers in Clinical Practice
Next-Level Diagnostics
with MeMed BV™
The MeMed BV™ diagnostic platform revolutionizes infection diagnostics by rapidly analyzing host immune response within 15 minutes, combining biomarkers (CRP, IP-10, TRAIL) into an actionable diagnostic score. Advantages include rapid results, accurate differentiation of bacterial and viral infections, and streamlined clinical decisions.
MeMed Severity:
Advanced Patient Risk Stratification
MeMed Severity is designed to enhance patient care by accurately stratifying disease severity and patient risk. Utilizing biomarkers combined into a predictive algorithm, MeMed Severity helps clinicians identify patients at higher risk for severe outcomes, and ruling out patients at low risk, enabling proactive management and optimized resource allocation. Clinical studies suggest its ability to potentially improve decision-making, patient monitoring, and overall clinical outcomes.
Artificial Intelligence:
Enhancing Diagnostic
Precision
Machine learning and artificial intelligence applications have transformed diagnostic accuracy by analyzing complex biomarker data and patient information. AI-driven algorithms rapidly interpret biomarker signatures, predict infection types, and assist clinicians in making precise, timely decisions, ultimately improving patient outcomes and streamlining infection management processes.
1
Initial
biomarker
measurement
2
Data
input
3
Algorithmic
processing
4
Predictive outcome generation
5
Enhanced
decisions